Sponsored Links
| Biothera Initiates Dosing In A Phase III Trial In Colorectal Cancer Patients |
 |
 |
 |
| Medical News - Colorectal Cancer | |||
|
Biothera began dosing patients today in a Phase III trial evaluating Imprime PGG® in combination with cetuximab (Erbitux®) as a potential new treatment for recurrent or progressive KRAS wild-type colorectal cancer. The trial design is built on data obtained in the company's previous clinical studies in colorectal cancer... Read more: Colorectal Cancer News From Medical News Today
|